Decision of the EEA Joint Committee No 297/2015 of 11 December 2015 amending Annex I (Veterinary and phytosanitary matters) and Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2017/1808]
Date: 2015-12-11
Institutions: EEA Joint Committee
Subjects: European Economic Area, agricultural product, chemical product, food safety, foodstuff, market approval, pesticide residue, plant health control, plant health product, revision of an agreement




L_2017263EN.01000501.xml










12.10.2017   


EN


Official Journal of the European Union


L 263/5








            DECISION OF THE EEA JOINT COMMITTEE
         
No 297/2015
of 11 December 2015
         
amending Annex I (Veterinary and phytosanitary matters) and Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2017/1808]


THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (‘the EEA Agreement’), and in particular Article 98 thereof,

Whereas:







(1)


Commission Regulation (EU) 2015/845 of 27 May 2015 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for azoxystrobin, chlorantraniliprole, cyantraniliprole, dicamba, difenoconazole, fenpyroximate, fludioxonil, glufosinate-ammonium, imazapic, imazapyr, indoxacarb, isoxaflutole, mandipropamid, penthiopyrad, propiconazole, pyrimethanil, spirotetramat and trinexapac in or on certain products (1) is to be incorporated into the EEA Agreement.












(2)


Commission Regulation (EU) 2015/846 of 28 May 2015 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for acetamiprid, ametoctradin, amisulbrom, bupirimate, clofentezine, ethephon, ethirimol, fluopicolide, imazapic, propamocarb, pyraclostrobin and tau-fluvalinate in or on certain products (2) is to be incorporated into the EEA Agreement.












(3)


Commission Regulation (EU) 2015/868 of 26 May 2015 amending Annexes II, III and V to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for 2,4,5-T, barban, binapacryl, bromophos-ethyl, camphechlor (toxaphene), chlorbufam, chloroxuron, chlozolinate, DNOC, di-allate, dinoseb, dinoterb, dioxathion, ethylene oxide, fentin acetate, fentin hydroxide, flucycloxuron, flucythrinate, formothion, mecarbam, methacrifos, monolinuron, phenothrin, propham, pyrazophos, quinalphos, resmethrin, tecnazene and vinclozolin in or on certain products (3), as corrected by OJ L 174, 3.7.2015, p. 43, is to be incorporated into the EEA Agreement.












(4)


Commission Regulation (EU) 2015/896 of 11 June 2015 amending Annex IV to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for Trichoderma polysporum strain IMI 206 039, Trichoderma asperellum (formerly T. harzianum) strains ICC012, T25 and TV1, Trichoderma atroviride (formerly T. harzianum) strains IMI 206 040 and T11, Trichoderma harzianum strains T-22 and ITEM 908, Trichoderma gamsii (formerly T. viride) strain ICC080, Trichoderma asperellum (strain T34), Trichoderma atroviride strain I-1237, geraniol, thymol, sucrose, ferric sulphate (iron (III) sulphate), ferrous sulphate (iron (II) sulphate) and folic acid in or on certain products (4) is to be incorporated into the EEA Agreement.












(5)


This Decision concerns legislation regarding feedingstuffs and foodstuffs. Legislation regarding feedingstuffs and foodstuffs shall not apply to Liechtenstein as long as the application of the Agreement between the European Community and the Swiss Confederation on trade in agricultural products is extended to Liechtenstein, as specified in the sectoral adaptations to Annex I and the introduction to Chapter XII of Annex II to the EEA Agreement. This Decision is therefore not to apply to Liechtenstein.












(6)


Annexes I and II to the EEA Agreement should therefore be amended accordingly,





HAS ADOPTED THIS DECISION:



Article 1
The following indents are added in point 40 (Regulation (EC) No 396/2005 of the European Parliament and of the Council) of Chapter II of Annex I to the EEA Agreement:






‘—



32015 R 0845: Commission Regulation (EU) 2015/845 of 27 May 2015 (OJ L 138, 4.6.2015, p. 1),










—



32015 R 0846: Commission Regulation (EU) 2015/846 of 28 May 2015 (OJ L 140, 5.6.2015, p. 1),










—



32015 R 0868: Commission Regulation (EU) 2015/868 of 26 May 2015 (OJ L 145, 10.6.2015, p. 1),










—



32015 R 0896: Commission Regulation (EU) 2015/896 of 11 June 2015 (OJ L 147, 12.6.2015, p. 3).’.






Article 2
The following indents are added in point 54zzy (Regulation (EC) No 396/2005 of the European Parliament and of the Council) of Chapter XII of Annex II to the EEA Agreement:






‘—



32015 R 0845: Commission Regulation (EU) 2015/845 of 27 May 2015 (OJ L 138, 4.6.2015, p. 1),










—



32015 R 0846: Commission Regulation (EU) 2015/846 of 28 May 2015 (OJ L 140, 5.6.2015, p. 1),










—



32015 R 0868: Commission Regulation (EU) 2015/868 of 26 May 2015 (OJ L 145, 10.6.2015, p. 1),










—



32015 R 0896: Commission Regulation (EU) 2015/896 of 11 June 2015 (OJ L 147, 12.6.2015, p. 3).’.






Article 3
The texts of Regulations (EU) 2015/845, (EU) 2015/846, (EU) 2015/868 and (EU) 2015/896 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.


Article 4
This Decision shall enter into force on 12 December 2015, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).


Article 5
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.




Done at Brussels, 11 December 2015.


For the EEA Joint Committee


The President

Oda SLETNES
            





(1)  
            OJ L 138, 4.6.2015, p. 1.

(2)  
            OJ L 140, 5.6.2015, p. 1.

(3)  
            OJ L 145, 10.6.2015, p. 1.

(4)  
            OJ L 147, 12.6.2015, p. 3.

(*1)  No constitutional requirements indicated.